UNSPSC 51342301: Valaciclovir or valacyclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C13H20N6O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier MZ1IW7Q79D, chemically known as valaciclovir, valtrex but more generally known as valaciclovir, which bears U.S. National Institutes of Health Compound Identifier 60773. The European Medicines Agency schedules Valaciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00003MIG.

UNSPSC 51342301 Valaciclovir or valacyclovir is a Commodity code nominally covering a specific antiviral pharmaceutical, but the recent state and local opportunities posted under it show little alignment with that scope. The code appears in records tagged to a range of health and medical procurement activities—naloxone and drug deactivation systems, medical and first aid supplies for fire rescue operations, generic pharmaceuticals through cooperative purchasing, and direct-to-manufacturer prescription program planning—none of which center on valaciclovir specifically. State and local agencies issuing under this code include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance). The mismatch between the code's nominal scope and the actual work being solicited suggests that state and local procurement systems may be applying this Commodity code as a catch-all for pharmaceutical procurement rather than reserving it for valaciclovir transactions.

Recent activity spans Florida, Texas, Minnesota, and Oregon. The most visible recent opportunity is the City of Tampa's IFB 26P00145 for medical and first aid supplies ($700,000 estimated value, due March 13, 2026), designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount; Seminole County's naloxone procurement (IFB 60459723LAS, quarterly deliveries starting in Sanford, Florida) represents community health purchasing; the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026) targets state and local government facilities across multiple jurisdictions; and the Texas HHS Commission's RFI HHS0017013 on direct-to-manufacturer prescription programs (posted April 3, 2026) signals exploratory procurement in pharmaceutical distribution strategy. The code shows little relevant recent activity specifically tied to valaciclovir procurement.